Lack of effect of aspirin in primary CV prevention in type 2 diabetic patients with nephropathy: results from 8 years follow-up of NID-2 study.

MLA

Sasso, Ferdinando Carlo, et al. “Lack of Effect of Aspirin in Primary CV Prevention in Type 2 Diabetic Patients with Nephropathy: Results from 8 Years Follow-up of NID-2 Study.” Acta Diabetologica, vol. 52, no. 2, Apr. 2015, pp. 239–47. EBSCOhost, https://doi.org/10.1007/s00592-014-0623-x.

APA

Sasso, F. C., Marfella, R., Pagano, A., Porta, G., Signoriello, G., Lascar, N., Minutolo, R., Carbonara, O., Persico, M., Piscione, F., De Nicola, L., Torella, R., & Paolisso, G. (2015). Lack of effect of aspirin in primary CV prevention in type 2 diabetic patients with nephropathy: results from 8 years follow-up of NID-2 study. Acta Diabetologica, 52(2), 239–247. https://doi.org/10.1007/s00592-014-0623-x

Chicago

Sasso, Ferdinando Carlo, Raffaele Marfella, Antonio Pagano, Giovanni Porta, Giuseppe Signoriello, Nadia Lascar, Roberto Minutolo, et al. 2015. “Lack of Effect of Aspirin in Primary CV Prevention in Type 2 Diabetic Patients with Nephropathy: Results from 8 Years Follow-up of NID-2 Study.” Acta Diabetologica 52 (2): 239–47. doi:10.1007/s00592-014-0623-x.